Analgesic nephropathy: Clinical features and pathogenesis. Original data on the incidence and prevalence in a single renal unit

Acta Clinica Belgica

Volumn 53, Issue 5, 1998, Pages 311-318

  Lornoy, W ^a   Becaus, I ^a   Billiouw, J M ^a   Sierens, L ^a  

^a OL Vrouwziekenhuis   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PARACETAMOL; PHENAZONE;

ANALGESIC AGENT ABUSE; ANALGESIC NEPHROPATHY; ARTICLE; CLINICAL FEATURE; DIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; PATHOGENESIS;

ADULT; AGE FACTORS; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DIAGNOSTIC IMAGING; DRUG COMBINATIONS; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; KIDNEY PAPILLARY NECROSIS; MALE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; PHENACETIN; PYRAZOLES; PYRAZOLONES; RENAL DIALYSIS;

EID: 0031761783     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Spuhler O, Zollinger HU. Die chronische interstitielle nephritis . Z Klin Med. 1953; 151: 1.
2. Verberckmoes R, Geuens H, Michielsen P. Nierinsufficiëntie na misbruik van fenacetine-houdende analgetica.Tijdschr Geneesk. 1964, 18: 954.
3. Segaert M, Michielsen P, Verberckmoes R, Vandenbroucke J. Misbruik van fenacetine-houdende preparaten. Tijdschr Geneesk. 1970; 18: 891.
4. Lornoy W, Ringoir S, Lameire N, De Broe M. Chronische interstitiële nefritis door misbruik van fenacetinehoudende analgetica. Tijdschr Geneesk. 1971; 8: 339.
5. Schweingruber R. Probleme der chronischen Vergiftung mit kombinierten Phenacetinpräparaten. Schweitz med Wehr. 1955; 85: 1162.
6. Grimlund K. Phenacetin and renal damage at a Swedish Factory. Acta Med Scand. 1963; suppl. 405.
7. Lornoy W, Roose R, De Paepe M, Becaus I, Laeveren A. Analgetica-nefropathie in 3 Oostvlaamse nefrologische diensten, gelegen in een streek met hoge prevalentie van analgetica abusus. Gegevens van 1981 tot en met 1986. Tijdschr Geneesk. 1988; 4: 243.
8. Lornoy W, Becaus I, Billiouw JM, Schatteman L. Circumstances of analgesic abuse in the Aalst area. Nephrol Dial Transplant. 1992; 7: 974.
9. Lornoy W, Becaus I, Morelle V, Fonteyne E. Néphropathies chroniques par abus d'analgésiques: fréquence, pathogenèse, aspects cliniques, développement de tumeurs malignes. Extrait des Séminaires d'uro-néphrologie 14ème série, 1988. Ed. Masson.
10. Hultengren N, Lagcrgren C, Ljunqvist A. Carcinoma of the renal pelvis in renal papillary necrosis. Acta chir Scand. 1965; 130: 314.
11. Lornoy W, Becaus I, De Vleeschouwer M, Morelle V, Fonteyne E, Thienpont L, Mestdagh J. Renal cell carcinoma, a new complication of analgesic nephropathy. The Lancet. 1986; Vol 1: 1271.
12. Elseviers MM, De Schepper A, Corthouts R, Bosmans JL, Cosyn L, Lins RL, Lornoy W, Matthys E, Roose R, Van Caesbroeck D, Waller I, Horackova M, Schwarz A, Svrcek P, Bonucchi D, Franck E, Morlans M, De Broe ME. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int. 1995; 48: 1316.
13. Lameire N, Ringoir S, De Broe M, Daneels R et Lornoy W. Evolution clinique de la néphrite interstitielle chronique par phénacétine après l'arrêt de l'abus de l'analgésique. J Urol Nephrol. 1970; 76: 993.
14. Kincaid-Smith P. Analgesic nephropathy: a common form of renal disease in Australia. Med J Aust. 1969; 2: 1131.
15. Bengtsson U, Johansson S, Angervall L. Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int. 1978; 13: 107.
16. Gault MH, Wilson DR. Analgesic nephropathy in Canada: clinical syndrome, management, and outcome. Kidney Int. 1978; 13: 58.
17. Larsen K, Moller CE. A renal lesion caused by abuse of Phenacetin. Acta Med Scand. 1959; 1164: 53.
18. Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesic containing phenacetin; renal morbidity and mortality (1968-1979). N Engl J Med. 1983; 308: 365.
19. Schwarz A. Analgesic-associated nephropathy. Klin Wochenschr. 1987; 65: 1.
20. MacDonald IM, Dumble LJ and Kincaid-Smith P. HLA-A3, vesico-ureteric reflux and analgesic abuse: in 1st Int. Symp. on HLA and Dis. Paris 1976.
21. Lornoy W, Sierens L, Becaus I, Billiouw JM. Gegevens van HLA-A, B, DR antigenen bij patiënten met analgetica nefropathie. Abstracts N.F.W.O. 1990.
22. Vanherweghem JL, Even-Adin D. Epidemiology of analgesic nephropathy in Belgium. Clin Nephrol. 1982; 17: 129.
23. Nanra RS. Analgesic-related renal disease. XIVth Int. Congress Nephrology. Breakfast Session: drug-induced interstitial renal disease, May 27, 1997: 57.
24. Brunner FP, Richtmann L, Thiel G, Dubach UC. Tumoren der ableitenden Harnwege und Analgetika-Abusus. Schweiz Med Wschr. 1978; 108: 1013.
25. Miller JA, Miller E. The metabolic activation of carcinogenic aromatic amines and amides. Prog Exp Tumors Res. 1969; 11. 273.
26. Batata M, Grabstald H. Upper urinary tract urothelial tumors. Urol Cl N Amer. 1976; 3: 79.
27. Thienpont L, Mestdagh J, Morelle V, Fonteyne E, De Galan JL, Lornoy W, Becaus I. Current practice of urinary cytology. A four-year-practice review with 3.995 cytological specimens examined. Acta Urol Belg. 1983; 51: 18.
28. Kliem V, Thon W, Krautzig S, Kolditz M, Behrend M, Pichlmayr R, Koch M, Frei U, Brunkhorst R. High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation. Transpl Int. 1996; 9: 231.
29. Lornoy W, Becaus I, Billiouw JM, Sierens L. Analgesic nephropathy may also be caused by abuse of analgesic mixtures without phenacetin or paracetamol. Eur Renal Assoc. EDTA, book of Abstract 1992; 76.
30. Michielsen P, De Schepper P. Analgetica nefropathie. Is een nieuwe reglementering vereist? Tijdschr Geneesk. 1996; 52: 1429.
31. Elseviers MM, De Broe ME. A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int. 1995; 48: 1912.
32. Annual report of the EDTA-ERA 1993.
33. Kincaid-Smith P. Analgesic nephropathy in Australia (1959-1984). In: Analgesic nephropathy Symposium. December 1st, 1984; 21-27. Antwerp.